Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol., Jojima Teruo;Sakurai Shintaro;Wakamatsu Sho;Iijima Toshie;Saito Masahiro;Tomaru Takuya;Kogai Takahiko;Usui Isao;Aso Yoshimasa, International journal of cardiology, 331, 243-248, 2021年02月05日